Untitled 3

Source R&D is the authoritative source of technology and services information supporting pharmaceutical and biotechnology companies in their drug discovery and development research projects.

Source R&D features extensive listings of service providers classified under company or organisation type, including contract chemical manufacturers; contract biologics manufacturers; biological research companies and organisations; and companies and organisations providing advisory, consultancy, legal, regulatory and other services.

The extensive coverage of Source R&D and the support of life sciences organisations One Nucleus and Bionow make it an invaluable reference tool that streamlines the vendor selection process to bring pharmaceutical/biotechnology companies and suppliers together.

Chemspace and LabNetwork collaborate to extend access to chemical databases

Chemspace and LabNetwork compound graphicOnline drug discovery chemicals marketplaces Chemspace and LabNetwork, a WuXi AppTec company, have entered into a collaboration agreement under which LabNetwork’s products will be available on www.chem-space.com, with distribution and technical support provided by Chemspace for European customers, thus expanding the market reach of both companies to pharma and biotech companies.

The Chemspace database encompasses more than 100 million chemical building blocks, fragments and screening compounds, its online catalogue including in-stock and make-on-demand molecules, and offering an easy, fast way to search using a broad range of filter options, such as substructure, similarity, and by using various text identifiers.

Use of the Chemspace database is free-of-charge and global chemistry suppliers, ranging from small to large organisations, are able to upload their catalogues to the site to provide an efficient solution for buyers when sourcing chemicals.

Dr Yurii Moroz, CEO at Chemspace, commented: “The collaboration with LabNetwork will provide drug discovery scientists, medicinal chemists, and academic researchers access to a vast diversity of high-quality products. We see a lot of synergy in our companies combining forces both from a business perspective and also to improve availability of compounds to the research community ultimately to shorten the drug discovery process in the hope of finding better cures for patients, quicker.”

For further information about Chemspace visit www.chem-space.com and for further information about LabNetwork visit www.labnetwork.com

Last modified onThursday, 11 April 2019 10:04